Status:
COMPLETED
Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Methamphetamine Dependence
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
This study is to assess the efficacy of bupropion in reducing methamphetamine use in subjects with methamphetamine dependence who report using methamphetamine 29 or less days during the 30 days prior ...
Detailed Description
The primary objective of this study is to assess the efficacy of bupropion in reducing methamphetamine use in subjects with methamphetamine dependence who report using methamphetamine 29 or less days ...
Eligibility Criteria
Inclusion
- Must have a DSM-IV diagnosis of methamphetamine dependence as determined by MINI
- Must have at least 1 amphetamine or methamphetamine positive urine specimen after the start of screening and before randomization or provide information to verify recent use if a positive urine sample can't be obtained
- Must report using methamphetamine for 29 days or less during the 30 day period prior signing consent using the timeline follow-back method
- Must be willing and able to comply with study procedures
- Must be able to verbalize and understand consent forms and provide written informed consent
- Must be seeking treatment for methamphetamine dependence
Exclusion
- Please contact study site for more information
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00687713
Start Date
May 1 2008
End Date
May 1 2011
Last Update
March 21 2017
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Integrated Substance Abuse Program
Los Angeles, California, United States, 90025
2
South Bay Treatment Center
San Diego, California, United States, 92115
3
Addiction and Pharmacology Research Laboratory
San Francisco, California, United States, 94110
4
Friends Research Institute
Torrance, California, United States, 90502